文献速递生殖医学

经皮睾酮预处理可提高低反应者的活产率:一项系统综述与Meta分析

Higher live birth rate following transdermal testosterone pretreatment in poor responders: a systematic review and meta-analysis.
PubMed 文献 · Reprod Biomed Online · 2022-10-07

该系统综述与Meta分析纳入8项RCT、797名低反应女性,评估经皮睾酮凝胶预处理(10-12.5 mg/天,10-56天)对IVF结局的影响。结果显示睾酮预处理与显著更高的活产率(RR 2.07,95%CI 1.09-3.92)和临床妊娠率(RR 2.25,95%CI 1.54-3.30)相关,并增加获卵数、减少刺激天数和促性腺激素总量。

要点

  • 经皮睾酮预处理与低反应者活产率显著升高相关(RR 2.07,95%CI 1.09-3.92)。
  • 临床妊娠率亦显著升高(RR 2.25,95%CI 1.54-3.30),获卵数增加。
  • 刺激天数更短、促性腺激素总量更低、因低反应取消率更低、扳机日内膜更厚。

核心结论

  • 经皮睾酮预处理的低反应者在IVF卵巢刺激中妊娠概率增加。

研究设计与样本

  • 系统综述与Meta分析,纳入8项RCT,共797名低反应女性。
  • 所有研究使用经皮睾酮凝胶,剂量10-12.5 mg/天,持续10-56天。

主要发现

  • 睾酮预处理组活产率显著高于对照组(RR 2.07,95%CI 1.09-3.92)。
  • 临床妊娠率显著高于对照组(RR 2.25,95%CI 1.54-3.30)。
  • 获卵数显著增加,完成卵巢刺激天数显著减少,促性腺激素总量显著降低。
  • 因低反应取消率显著降低,扳机日子宫内膜显著增厚。
  • 雌二醇浓度、≥17 mm卵泡数、MII卵母细胞数、2PN卵母细胞数、移植胚胎数及胚胎移植患者比例无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A systematic review and meta-analysis was performed aiming to identify good-quality randomized controlled trials (RCT) evaluating testosterone pretreatment in poor responders. Eight RCTs were analysed, evaluating 797 women. Transdermal testosterone gel was used in all studies, with a dose ranging from 10 to 12.5 mg/day for 10-56 days. The main outcome measure was achievement of pregnancy, expressed as clinical pregnancy or live birth. Testosterone pretreatment was associated with a significantly higher live birth (risk ratio [RR] 2.07, 95% confidence interval [CI] 1.09-3.92) and clinical pregnancy rate (RR 2.25, 95% CI 1.54-3.30), as well as a significant increase in the number of cumulus-oocyte complexes retrieved. Significantly fewer days to complete ovarian stimulation, a lower total dose of gonadotrophins, a lower cancellation rate due to poor ovarian response and a thicker endometrium on the day of triggering of final oocyte maturation were observed. No significant differences were observed in oestradiol concentration, the numbers of follicles ≥17 mm, metaphase II oocytes, two-pronuclear oocytes and embryos transferred, and the proportion of patients with embryo transfer. The current study suggests that the probability of pregnancy is increased in poor responders pretreated with transdermal testosterone who are undergoing ovarian stimulation for IVF.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Katsika ET, Bosdou JK, Goulis DG, et al. Higher live birth rate following transdermal testosterone pretreatment in poor responders: a systematic review and meta-analysis. Reprod Biomed Online. 2022. PMID: 36369150. doi:10.1016/j.rbmo.2022.09.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。